AMBER CHEWNING: Open Payments
NPI 1316520307 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 8 payments from 7 companies in 2025. Trend: 2023 $541 · 2024 $300 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Boston Scientific Corporation | 1 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Novo Nordisk Inc | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: Kerendia, WATCHMAN Access System, ONPATTRO, LEQVIO, Wegovy, VYNDAQEL, FARXIGA.
Industry payments across FL — which companies pay providers there.
